INS and neoplasm: This anticancer effect may be due to metformin’s ability to activate AMP-activated protein kinase in PC-3 cell lines, inhibiting protein synthesis in tumor cells and reducing insulin levels.[48] However, the use of antidiabetic drugs has not yet been proven to reduce the incidence of EC.